Publication Information

{'id': 'https://openalex.org/W1979518602', 'doi': 'https://doi.org/10.4088/jcp.v62n0404', 'title': 'Factors Influencing Acute Weight Change in Patients With Schizophrenia Treated With Olanzapine, Haloperidol, or Risperidone', 'display_name': 'Factors Influencing Acute Weight Change in Patients With Schizophrenia Treated With Olanzapine, Haloperidol, or Risperidone', 'publication_year': 2001, 'publication_date': '2001-04-15', 'ids': {'openalex': 'https://openalex.org/W1979518602', 'doi': 'https://doi.org/10.4088/jcp.v62n0404', 'mag': '1979518602', 'pmid': 'https://pubmed.ncbi.nlm.nih.gov/11379836'}, 'language': 'en', 'primary_location': {'is_oa': False, 'landing_page_url': 'https://doi.org/10.4088/jcp.v62n0404', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S17992710', 'display_name': 'The Journal of Clinical Psychiatry', 'issn_l': '0160-6689', 'issn': ['0160-6689', '1534-8628', '1555-2101'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4322614534', 'host_organization_name': 'Physicians Postgraduate Press, Inc.', 'host_organization_lineage': ['https://openalex.org/P4322614534'], 'host_organization_lineage_names': ['Physicians Postgraduate Press, Inc.'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, 'type': 'article', 'type_crossref': 'journal-article', 'indexed_in': ['crossref', 'pubmed'], 'open_access': {'is_oa': False, 'oa_status': 'closed', 'oa_url': None, 'any_repository_has_fulltext': False}, 'authorships': [{'author_position': 'first', 'author': {'id': 'https://openalex.org/A5050840013', 'display_name': 'Bruce R. Basson', 'orcid': None}, 'institutions': [{'id': 'https://openalex.org/I168537998', 'display_name': 'Eli Lilly (United States)', 'ror': 'https://ror.org/01qat3289', 'country_code': 'US', 'type': 'company', 'lineage': ['https://openalex.org/I168537998']}], 'countries': ['US'], 'is_corresponding': False, 'raw_author_name': 'Bruce R. Basson', 'raw_affiliation_strings': ['Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Ind 46285, USA.'], 'affiliations': [{'raw_affiliation_string': 'Lilly Research Laboratories, Eli Lilly and Company, Lilly Corporate Center, Indianapolis, Ind 46285, USA.', 'institution_ids': ['https://openalex.org/I168537998']}]}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5010145606', 'display_name': 'Bruce J. Kinon', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Bruce J. Kinon', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5075562229', 'display_name': 'Cindy C. Taylor', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Cindy C. Taylor', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5052092547', 'display_name': 'Keith Szymanski', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Keith A. Szymanski', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'middle', 'author': {'id': 'https://openalex.org/A5084910312', 'display_name': 'J. A. Gilmore', 'orcid': 'https://orcid.org/0000-0002-4822-5386'}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Julie A. Gilmore', 'raw_affiliation_strings': [], 'affiliations': []}, {'author_position': 'last', 'author': {'id': 'https://openalex.org/A5109214489', 'display_name': 'Gary D. Tollefson', 'orcid': None}, 'institutions': [], 'countries': [], 'is_corresponding': False, 'raw_author_name': 'Gary D. Tollefson', 'raw_affiliation_strings': [], 'affiliations': []}], 'institution_assertions': [], 'countries_distinct_count': 1, 'institutions_distinct_count': 1, 'corresponding_author_ids': [], 'corresponding_institution_ids': [], 'apc_list': None, 'apc_paid': None, 'fwci': 8.822, 'has_fulltext': False, 'cited_by_count': 280, 'citation_normalized_percentile': {'value': 0.999821, 'is_in_top_1_percent': True, 'is_in_top_10_percent': True}, 'cited_by_percentile_year': {'min': 98, 'max': 99}, 'biblio': {'volume': '62', 'issue': '4', 'first_page': '231', 'last_page': '238'}, 'is_retracted': False, 'is_paratext': False, 'primary_topic': {'id': 'https://openalex.org/T10023', 'display_name': 'Schizophrenia research and treatment', 'score': 0.9973, 'subfield': {'id': 'https://openalex.org/subfields/2738', 'display_name': 'Psychiatry and Mental health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, 'topics': [{'id': 'https://openalex.org/T10023', 'display_name': 'Schizophrenia research and treatment', 'score': 0.9973, 'subfield': {'id': 'https://openalex.org/subfields/2738', 'display_name': 'Psychiatry and Mental health'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T12267', 'display_name': 'Diet and metabolism studies', 'score': 0.9896, 'subfield': {'id': 'https://openalex.org/subfields/2737', 'display_name': 'Physiology'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}, {'id': 'https://openalex.org/T11967', 'display_name': 'Electrolyte and hormonal disorders', 'score': 0.9716, 'subfield': {'id': 'https://openalex.org/subfields/2740', 'display_name': 'Pulmonary and Respiratory Medicine'}, 'field': {'id': 'https://openalex.org/fields/27', 'display_name': 'Medicine'}, 'domain': {'id': 'https://openalex.org/domains/4', 'display_name': 'Health Sciences'}}], 'keywords': [{'id': 'https://openalex.org/keywords/dopamine-antagonist', 'display_name': 'Dopamine antagonist', 'score': 0.6051671}], 'concepts': [{'id': 'https://openalex.org/C2776619155', 'wikidata': 'https://www.wikidata.org/wiki/Q201872', 'display_name': 'Olanzapine', 'level': 3, 'score': 0.9648496}, {'id': 'https://openalex.org/C2780948584', 'wikidata': 'https://www.wikidata.org/wiki/Q251347', 'display_name': 'Haloperidol', 'level': 3, 'score': 0.8592356}, {'id': 'https://openalex.org/C2780057945', 'wikidata': 'https://www.wikidata.org/wiki/Q412443', 'display_name': 'Risperidone', 'level': 3, 'score': 0.8546051}, {'id': 'https://openalex.org/C2780320433', 'wikidata': 'https://www.wikidata.org/wiki/Q3403879', 'display_name': 'Weight gain', 'level': 3, 'score': 0.68734807}, {'id': 'https://openalex.org/C2780494398', 'wikidata': 'https://www.wikidata.org/wiki/Q208144', 'display_name': 'Antipsychotic', 'level': 3, 'score': 0.6748514}, {'id': 'https://openalex.org/C2781353949', 'wikidata': 'https://www.wikidata.org/wiki/Q3271533', 'display_name': 'Dopamine antagonist', 'level': 4, 'score': 0.6051671}, {'id': 'https://openalex.org/C15744967', 'wikidata': 'https://www.wikidata.org/wiki/Q9418', 'display_name': 'Psychology', 'level': 0, 'score': 0.5300258}, {'id': 'https://openalex.org/C71924100', 'wikidata': 'https://www.wikidata.org/wiki/Q11190', 'display_name': 'Medicine', 'level': 0, 'score': 0.48972133}, {'id': 'https://openalex.org/C126322002', 'wikidata': 'https://www.wikidata.org/wiki/Q11180', 'display_name': 'Internal medicine', 'level': 1, 'score': 0.48450845}, {'id': 'https://openalex.org/C2776921671', 'wikidata': 'https://www.wikidata.org/wiki/Q758295', 'display_name': 'Atypical antipsychotic', 'level': 4, 'score': 0.4803751}, {'id': 'https://openalex.org/C2776412080', 'wikidata': 'https://www.wikidata.org/wiki/Q7431605', 'display_name': 'Schizophrenia (object-oriented programming)', 'level': 2, 'score': 0.43521154}, {'id': 'https://openalex.org/C118552586', 'wikidata': 'https://www.wikidata.org/wiki/Q7867', 'display_name': 'Psychiatry', 'level': 1, 'score': 0.335421}, {'id': 'https://openalex.org/C147583825', 'wikidata': 'https://www.wikidata.org/wiki/Q620876', 'display_name': 'Body weight', 'level': 2, 'score': 0.1046035}, {'id': 'https://openalex.org/C513476851', 'wikidata': 'https://www.wikidata.org/wiki/Q170304', 'display_name': 'Dopamine', 'level': 2, 'score': 0.0508765}], 'mesh': [{'descriptor_ui': 'D014150', 'descriptor_name': 'Antipsychotic Agents', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D001835', 'descriptor_name': 'Body Weight', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': True}, {'descriptor_ui': 'D006220', 'descriptor_name': 'Haloperidol', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D010890', 'descriptor_name': 'Pirenzepine', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D010890', 'descriptor_name': 'Pirenzepine', 'qualifier_ui': 'Q000031', 'qualifier_name': 'analogs & derivatives', 'is_major_topic': True}, {'descriptor_ui': 'D018967', 'descriptor_name': 'Risperidone', 'qualifier_ui': 'Q000627', 'qualifier_name': 'therapeutic use', 'is_major_topic': True}, {'descriptor_ui': 'D012559', 'descriptor_name': 'Schizophrenia', 'qualifier_ui': 'Q000188', 'qualifier_name': 'drug therapy', 'is_major_topic': True}, {'descriptor_ui': 'D000328', 'descriptor_name': 'Adult', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000367', 'descriptor_name': 'Age Factors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D014150', 'descriptor_name': 'Antipsychotic Agents', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D014150', 'descriptor_name': 'Antipsychotic Agents', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001066', 'descriptor_name': 'Appetite', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}, {'descriptor_ui': 'D001066', 'descriptor_name': 'Appetite', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001569', 'descriptor_name': 'Benzodiazepines', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015992', 'descriptor_name': 'Body Mass Index', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D001835', 'descriptor_name': 'Body Weight', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010054', 'descriptor_name': 'Brief Psychiatric Rating Scale', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010054', 'descriptor_name': 'Brief Psychiatric Rating Scale', 'qualifier_ui': 'Q000706', 'qualifier_name': 'statistics & numerical data', 'is_major_topic': False}, {'descriptor_ui': 'D004305', 'descriptor_name': 'Dose-Response Relationship, Drug', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D004311', 'descriptor_name': 'Double-Blind Method', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005260', 'descriptor_name': 'Female', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D005500', 'descriptor_name': 'Follow-Up Studies', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006220', 'descriptor_name': 'Haloperidol', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D006220', 'descriptor_name': 'Haloperidol', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D006801', 'descriptor_name': 'Humans', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D008297', 'descriptor_name': 'Male', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D000077152', 'descriptor_name': 'Olanzapine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D010890', 'descriptor_name': 'Pirenzepine', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D010890', 'descriptor_name': 'Pirenzepine', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D044469', 'descriptor_name': 'Racial Groups', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012189', 'descriptor_name': 'Retrospective Studies', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012307', 'descriptor_name': 'Risk Factors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018967', 'descriptor_name': 'Risperidone', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D018967', 'descriptor_name': 'Risperidone', 'qualifier_ui': 'Q000494', 'qualifier_name': 'pharmacology', 'is_major_topic': False}, {'descriptor_ui': 'D012559', 'descriptor_name': 'Schizophrenia', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D012737', 'descriptor_name': 'Sex Factors', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D016896', 'descriptor_name': 'Treatment Outcome', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015430', 'descriptor_name': 'Weight Gain', 'qualifier_ui': '', 'qualifier_name': None, 'is_major_topic': False}, {'descriptor_ui': 'D015430', 'descriptor_name': 'Weight Gain', 'qualifier_ui': 'Q000187', 'qualifier_name': 'drug effects', 'is_major_topic': False}], 'locations_count': 2, 'locations': [{'is_oa': False, 'landing_page_url': 'https://doi.org/10.4088/jcp.v62n0404', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S17992710', 'display_name': 'The Journal of Clinical Psychiatry', 'issn_l': '0160-6689', 'issn': ['0160-6689', '1534-8628', '1555-2101'], 'is_oa': False, 'is_in_doaj': False, 'is_core': True, 'host_organization': 'https://openalex.org/P4322614534', 'host_organization_name': 'Physicians Postgraduate Press, Inc.', 'host_organization_lineage': ['https://openalex.org/P4322614534'], 'host_organization_lineage_names': ['Physicians Postgraduate Press, Inc.'], 'type': 'journal'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}, {'is_oa': False, 'landing_page_url': 'https://pubmed.ncbi.nlm.nih.gov/11379836', 'pdf_url': None, 'source': {'id': 'https://openalex.org/S4306525036', 'display_name': 'PubMed', 'issn_l': None, 'issn': None, 'is_oa': False, 'is_in_doaj': False, 'is_core': False, 'host_organization': 'https://openalex.org/I1299303238', 'host_organization_name': 'National Institutes of Health', 'host_organization_lineage': ['https://openalex.org/I1299303238'], 'host_organization_lineage_names': ['National Institutes of Health'], 'type': 'repository'}, 'license': None, 'license_id': None, 'version': None, 'is_accepted': False, 'is_published': False}], 'best_oa_location': None, 'sustainable_development_goals': [{'id': 'https://metadata.un.org/sdg/3', 'score': 0.53, 'display_name': 'Good health and well-being'}], 'grants': [], 'datasets': [], 'versions': [], 'referenced_works_count': 0, 'referenced_works': [], 'related_works': ['https://openalex.org/W3109919181', 'https://openalex.org/W2187101648', 'https://openalex.org/W2116605562', 'https://openalex.org/W2076931387', 'https://openalex.org/W2070273471', 'https://openalex.org/W2040013231', 'https://openalex.org/W1990165054', 'https://openalex.org/W1979518602', 'https://openalex.org/W1966607506', 'https://openalex.org/W1965702271'], 'abstract_inverted_index': {'Article': [0], 'AbstractObjective:': [1], 'Clinical': [2], 'factors': [3, 170, 179], 'predicting': [4], 'weightchange': [5], 'in': [6, 137, 175], 'patients': [7, 176], 'with': [8, 15, 162, 217], 'schizophrenia': [9], 'and': [10, 20, 36, 41, 44, 70, 95, 115, 145, 192, 199, 205], 'related': [11], 'disordersduring': [12], 'acute': [13, 172, 222], 'treatment': [14, 127], 'the': [16], 'antipsychotic': [17, 158, 181], 'drugs': [18, 182], 'olanzapine,risperidone,': [19], 'haloperidol': [21, 37, 146], 'were': [22, 49, 72, 142, 160], 'sought': [23], 'through': [24], 'retrospectiveanalyses.': [25], 'Method:': [26], 'Six-week': [27], 'body-weight': [28], 'data': [29], 'from': [30, 134], '2': [31], 'trials,study': [32], '1': [33], 'comparing': [34], 'olanzapine': [35, 43, 78, 103, 126, 150], '(N': [38, 46], '=': [39, 47], '1369)': [40], 'study2': [42], 'risperidone': [45], '268),': [48], 'analyzed.': [50], 'Effects': [51, 92], 'of8': [52], 'clinically': [53], 'relevant': [54], 'covariates--therapy,': [55], 'clinical': [56, 82, 111, 189], 'outcome(Brief': [57], 'Psychiatric': [58], 'Rating': [59], 'Scale),': [60], 'baseline': [61], 'body': [62], 'mass': [63], 'index(BBMI),': [64], 'increased': [65, 203], 'appetite,': [66], 'age,': [67], 'gender,': [68], 'race,': [69], 'dose--onweight': [71], 'compared.': [73], 'Results:': [74], 'In': [75, 108], 'study': [76, 109], '1,': [77], '(vs.haloperidol)': [79], 'therapy,': [80], 'better': [81, 188], 'outcome,': [83, 112], 'lower': [84, 113, 157, 163], 'BBMI,': [85, 114, 191], 'andnonwhite': [86], 'race': [87], 'significantly': [88, 132], 'affected': [89, 118], 'weight': [90, 99, 119, 140, 164, 173, 185, 223], 'gain.': [91, 120, 165, 224], 'ofincreased': [93], 'appetite': [94, 122, 204], 'male': [96], 'gender': [97], 'on': [98, 139, 221], 'gain': [100, 186], 'weresignificant': [101], 'for': [102, 106], 'but': [104, 147], 'not': [105, 148], 'haloperidol.': [107], '2,better': [110], 'younger': [116], 'agesignificantly': [117], 'Increased': [121], 'was': [123, 154, 214], 'morefrequent': [124], 'during': [125, 129], 'than': [128], 'haloperidol,': [130], 'butnot': [131], 'different': [133], 'risperidone.': [135], 'Significantdifferences': [136], 'effect': [138], 'change': [141, 174], 'found': [143, 155], 'betweenolanzapine': [144], 'between': [149], 'andrisperidone.': [151], 'No': [152], 'evidence': [153], 'that': [156], 'drugdoses': [159], 'associated': [161], 'Conclusion:': [166], 'This': [167], 'report': [168], 'identifiespredictive': [169], 'of': [171, 208, 215], 'withschizophrenia.': [177], 'Similar': [178], 'across': [180], 'inpredicting': [183], 'greater': [184], 'included': [187], 'outcome,low': [190], 'nonwhite': [193], 'race.': [194], 'Factors': [195], 'differing': [196], 'betweenconventional': [197], '(haloperidol)': [198], 'atypical': [200], '(olanzapine)': [201], 'agentsincluded': [202], 'gender.': [206], 'Choice': [207], 'atypicalantipsychotic': [209], 'drug': [210], '(olanzapine': [211], 'vs.': [212], 'risperidone)': [213], 'minorimportance': [216], 'regard': [218], 'to': [219], 'influence': [220]}, 'cited_by_api_url': 'https://api.openalex.org/works?filter=cites:W1979518602', 'counts_by_year': [{'year': 2024, 'cited_by_count': 2}, {'year': 2023, 'cited_by_count': 2}, {'year': 2022, 'cited_by_count': 5}, {'year': 2021, 'cited_by_count': 4}, {'year': 2020, 'cited_by_count': 4}, {'year': 2019, 'cited_by_count': 11}, {'year': 2018, 'cited_by_count': 6}, {'year': 2017, 'cited_by_count': 3}, {'year': 2016, 'cited_by_count': 12}, {'year': 2015, 'cited_by_count': 7}, {'year': 2014, 'cited_by_count': 8}, {'year': 2013, 'cited_by_count': 16}, {'year': 2012, 'cited_by_count': 16}], 'updated_date': '2024-12-24T14:56:37.837262', 'created_date': '2016-06-24'}